DA
QTTB icon

DCF Advisers’s Q32 Bio QTTB Stock Holding History

DCF Advisers’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$108K Buy
+13,000
New +$180K 0.02% 100

Other funds holding QTTB

Sanofi
Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $92B AUM 22.91% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return

DCF Advisers's QTTB Position: Q3 2026 in Review

DCF Advisers opened a new position in Q32 Bio (QTTB) in Q3 2026: 13,000 shares worth $108K. The stake represents 0.02% of the portfolio and ranks #100 among its holdings.

21 funds tracked by Wall St. Rank hold QTTB as of Q3 2026.

  • DCF Advisers held 13,000 shares of Q32 Bio worth $108K as of Q3 2026.
  • Q32 Bio was a new DCF Advisers position in Q3 2026.
  • Q32 Bio made up 0.02% of DCF Advisers's portfolio in Q3 2026, its #100 holding.
  • 21 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2026.

Based on DCF Advisers's 13F filing for Q3 2026, filed 4 Nov 2026.